Increased expression of (pro)renin receptor in the remnant kidneys of 5/6 nephrectomized rats

Regulatory Peptides

Volumn 159, Issue 1-3, 2010, Pages 93-99

  Hirose, Takuo ^a   Mori, Nobuyoshi ^a   Totsune, Kazuhito ^a,b   Morimoto, Ryo ^a   Maejima, Takahiro ^a   Kawamura, Takuya ^a   Metoki, Hirohito ^a   Asayama, Kei ^b   Kikuya, Masahiro ^a   Ohkubo, Takayoshi ^a,b   Kohzuki, Masahiro ^a   Takahashi, Kazuhiro ^a   Imai, Yutaka ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Organ damage; Renin angiotensin system; RT PCR; Western blot

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSINOGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MONOCLONAL ANTIBODY; PRORENIN RECEPTOR; RENIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; KIDNEY TUBULE CELL; MALE; NEPHRECTOMY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; GENE EXPRESSION REGULATION; KIDNEY GLOMERULUS; MALE; NEPHRECTOMY; RATS; RATS, INBRED WKY; RECEPTORS, CELL SURFACE; RENIN; RNA, MESSENGER;

RATTUS;

EID: 71349085194     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.11.006     Document Type: Article

References (41)

1. Weir M.R., and Dzau V.J. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 12 (1999) 205S-213S
2. Kim S., and Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52 (2000) 11-34
3. Dzau V.J., Bernstein K., Celermajer D., Cohen J., Dahlof B., Deanfield J., Diez J., Drexler H., Ferrari R., van Gilst W., Hansson L., Hornig B., Husain A., Johnston C., Lazar H., Lonn E., Luscher T., Mancini J., Mimran A., Pepine C., Rabelink T., Remme W., Ruilope L., Ruzicka M., Schunkert H., Swedberg K., Unger T., Vaughan D., and Weber M. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol 88 (2001) 1L-20L
4. Nguyen G., Delarue F., Berrou J., Rondeau E., and Sraer J.D. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 50 (1996) 1897-1903
5. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., and Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109 (2002) 1417-1427
6. Huang Y., Wongamorntham S., Kasting J., McQuillan D., Owens R.T., Yu L., Noble N.A., and Border W. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 69 (2006) 105-113
7. Burcklé C.A., Jan Danser A.H., Muller D.N., Garrelds I.M., Gasc J.M., Popova E., Plehm R., Peters J., Bader M., and Nguyen G. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 47 (2006) 552-556
8. Ichihara A., Hayashi M., Kaneshiro Y., Suzuki F., Nakagawa T., Tada Y., Koura Y., Nishiyama A., Okada H., Uddin M.N., Nabi A.H., Ishida Y., Inagami T., and Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest 114 (2004) 1128-1135
9. Ichihara A., Kaneshiro Y., Takemitsu T., Sakoda M., Nakagawa T., Nishiyama A., Kawachi H., Shimizu F., and Inagami T. Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 17 (2006) 2495-2503
10. Ichihara A., Kaneshiro Y., Takemitsu T., Sakoda M., Suzuki F., Nakagawa T., Nishiyama A., Inagami T., and Hayashi M. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 47 (2006) 894-900
11. Ichihara A., Suzuki F., Nakagawa T., Kaneshiro Y., Takemitsu T., Sakoda M., Nabi A.H., Nishiyama A., Sugaya T., Hayashi M., and Inagami T. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 17 (2006) 1950-1961
12. Kaneshiro Y., Ichihara A., Sakoda M., Takemitsu T., Nabi A.H., Uddin M.N., Nakagawa T., Nishiyama A., Suzuki F., Inagami T., and Itoh H. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol 18 (2007) 1789-1795
13. Takahashi H., Ichihara A., Kaneshiro Y., Inomata K., Sakoda M., Takemitsu T., Nishiyama A., and Itoh H. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol 18 (2007) 2054-2061
14. Hirose T., Hashimoto M., Totsune K., Metoki H., Asayama K., Kikuya M., Sugimoto K., Katsuya T., Ohkubo T., Hashimoto J., Rakugi H., Takahashi K., and Imai Y. Association of (Pro)renin receptor gene polymorphism with blood pressure in Japanese men: the Ohasama Study. Am J Hypertens 22 (2009) 294-299
15. Hirose T., Mori N., Totsune K., Morimoto R., Maejima T., Kawamura T., Metoki H., Asayama K., Kikuya M., Ohkubo T., Kohzuki M., Takahashi K., and Imai Y. Gene expression of (pro)renin receptor is upregulated in hearts and kidneys of rats with congestive heart failure. Peptides (Sep 16 2009) [Electronic publication ahead of print] PMID: 19765626
16. Kanazawa M., Kawamura T., Li L., Sasaki Y., Matsumoto K., Kataoka H., Ito O., Minami N., Sato T., Ootaka T., and Kohzuki M. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation. Am J Hypertens 19 (2006) 80-86
17. Mori N., Hirose T., Nakayama T., Ito O., Kanazawa M., Imai Y., Kohzuki M., Takahashi K., and Totsune K. Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure. Peptides 30 (2009) 400-408
18. Hirose T., Totsune K., Mori N., Morimoto R., Hashimoto M., Nakashige Y., Metoki H., Asayama K., Kikuya M., Ohkubo T., Hashimoto J., Sasano H., Kohzuki M., Takahashi K., and Imai Y. Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure. Eur J Heart Fail 10 (2008) 840-849
19. Totsune K., Mackenzie H.S., Totsune H., Troy J.L., Lytton J., and Brenner B.M. Upregulation of atrial natriuretic peptide gene expression in remnant kidney of rats with reduced renal mass. J Am Soc Nephrol 9 (1998) 1613-1619
20. Kato S., Luyckx V.A., Ots M., Lee K.W., Ziai F., Troy J.L., Brenner B.M., and MacKenzie H.S. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney Int 56 (1999) 1037-1048
21. Taal M.W., Chertow G.M., Rennke H.G., Gurnani A., Jiang T., Shahsafaei A., Troy J.L., Brenner B.M., and Mackenzie H.S. Mechanisms underlying renoprotection during renin-angiotensin system blockade. Am J Physiol Renal Physiol 280 (2001) F343-F355
22. Taal M.W., Zandi-Nejad K., Weening B., Shahsafaei A., Kato S., Lee K.W., Ziai F., Jiang T., Brenner B.M., and MacKenzie H.S. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 58 (2000) 1664-1676
23. Ishizuka T., Ito O., Tan L., Ogawa S., Kohzuki M., Omata K., Takeuchi K., and Ito S. Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidney. Hypertens Res 26 (2003) 929-936
24. Takahashi K., Kikuchi K., Maruyama Y., Urabe T., Nakajima K., Sasano H., Imai Y., Murakami O., and Totsune K. Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus, heart and kidney. Peptides 27 (2006) 1383-1389
25. Cousin C., Bracquart D., Contrepas A., Corvol P., Muller L., and Nguyen G. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension 53 (2009) 1077-1082
26. Siragy H.M., and Huang J. Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol 93 (2008) 709-714
27. Krebs C., Hamming I., Sadaghiani S., Steinmetz O.M., Meyer-Schwesinger C., Fehr S., Stahl R.A., Garrelds I.M., Danser A.H., van Goor H., Contrepas A., Nguyen G., and Wenzel U. Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int 72 (2007) 725-730
28. Junaid A., Rosenberg M.E., and Hostetter T.H. Interaction of angiotensin II and TGF-beta 1 in the rat remnant kidney. J Am Soc Nephrol 8 (1997) 1732-1738
29. Rosenberg M.E., Smith L.J., Correa-Rotter R., and Hostetter T.H. The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45 (1994) 403-410
30. Batenburg W.W., Krop M., Garrelds I.M., de Vries R., de Bruin R.J., Burckle C.A., Muller D.N., Bader M., Nguyen G., and Danser A.H. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens 25 (2007) 2441-2453
31. Nabi A.H., Kageshima A., Uddin M.N., Nakagawa T., Park E.Y., and Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med 18 (2006) 483-488
32. Hackenthal E., Paul M., Ganten D., and Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev 70 (1990) 1067-1116
33. Prieto-Carrasquero M.C., Harrison-Bernard L.M., Kobori H., Ozawa Y., Hering-Smith K.S., Hamm L.L., and Navar L.G. Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 44 (2004) 223-229
34. Prieto-Carrasquero M.C., Botros F.T., Pagan J., Kobori H., Seth D.M., Casarini D.E., and Navar L.G. Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats. Hypertension 51 (2008) 1590-1596
35. Kang J.J., Toma I., Sipos A., Meer E.J., Vargas S.L., and Peti-Peterdi J. The collecting duct is the major source of prorenin in diabetes. Hypertension 51 (2008) 1597-1604
36. Nishiyama A., Seth D.M., and Navar L.G. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39 (2002) 129-134
37. Graciano M.L., Cavaglieri R.C., Delle H., Dominguez W.V., Casarini D.E., Malheiros D.M., and Noronha I.L. Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15 (2004) 1805-1815
38. +-ATPase in the kidney. Hypertension 54 (2009) 261-269
39. Correa-Rotter R., Hostetter T.H., Manivel J.C., and Rosenberg M.E. Renin expression in renal ablation. Hypertension 20 (1992) 483-490
40. Nguyen G., and Contrepas A. Physiology and pharmacology of the (pro)renin receptor. Curr Opin Pharmacol 8 (2008) 127-132
41. Schefe J.H., Menk M., Reinemund J., Effertz K., Hobbs R.M., Pandolfi P.P., Ruiz P., Unger T., and Funke-Kaiser H. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 99 (2006) 1355-1366